But it also leads me to wanting to say its interesting, because if that had been our motivation to actually say, oh, there's weight loss in diabetes, let's pursue it in people with obesity, I don't think we would've done that because the weight loss in people with diabetes wasn't that impressive
Putting on my best normal: social camouflaging in adults with autism spectrum conditions
Combination Therapy Use of Semaglutide in Patients with Type 2 Diabetes Mellitus Combination with Metformin and/or Thiazolidinediones In a 56-week, double-blind trial (NCT01930188), 1231 patients with type 2 diabetes mellitus were randomized to semaglutide 0.5 mg once weekly, semaglutide 1 mg once weekly, or sitagliptin 100 mg once daily, all in combination with metformin (94%) and/or thiazolidinediones (6%)
A trend of decrease in total phospholipid level was noticed in Hitrechol TID (Group 5) in comparison to vehicle treated lithogenic diet group (Group 2) and Hitrechol (QD) treated Lithogenic diet group (Group 4), however, there was no statistically significant difference
Despite this, there are instances where the ability to synthesize GSH, and in turn establish an adaptive response is compromised
The degree and duration of each effect can vary by compound, dose and individual response